Month: <span>September 2019</span>

Home / 2019 / September
Post

Why young females with obesity are at early risk for cardiovascular disease

MEDICAL COLLEGE OF GEORGIA AT AUGUSTA UNIVERSITY AUGUSTA, Ga. (Sept. 11, 2019) – In the face of obesity, the sex hormone progesterone that helps females get and stay pregnant appears to also put them at increased, early risk for cardiovascular disease, investigators report.  Premenopausal women are considered protected from cardiovascular disease, but evidence indicates obesity can negate those benefits, and in fact put...

Post

Hemophilia three times more prevalent than thought

by Veronica Mcguire,  McMaster University More than 1,125,000 men around the world have the inherited bleeding disorder of hemophilia, and 418,000 of those have a severe version of the mostly undiagnosed disease, says a new study led by McMaster University researchers. This is three times what was previously known. Only 400,000 people globally were estimated to have the disorder which is caused...

Post

Here’s what you can eat and avoid to reduce your risk of bowel cancer

by Suzanne Mahady, The Conversation Australia has one of the highest rates of bowel cancer in the world. In 2017, bowel cancer was the second most common cancer in Australia and rates are increasing in people under 50. Up to 35% of cancers worldwide might be caused by lifestyle factors such as diet and smoking. So how can we go about reducing our risk of bowel cancer? What to eat Based on current evidence, a high...

Post

An oral splint that can reduce Tourette syndrome tics

Researchers at Osaka University develop an oral device that effectively reduces motor and vocal tics in patients with Tourette syndrome OSAKA UNIVERSITY Osaka, Japan – Tourette syndrome is a neurological disorder characterized by vocal and motor tics, which can contribute to anxiety, depression, and low self-esteem. Researchers in Japan have developed a removable dental appliance that can reduce these tics in...

Post

Lung cancer screening model favored in Europe detects more cancers than 1 preferred in the US

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Barcelona–Researchers reported today that a prospective trial comparing two screening methods for at-risk lung cancer patients found that a model used by Canadian, Australian and European public health organizations detected more cancers than the screening model used by the United States Preventive Services Task Force (USPSTF). The...

Post

Immunotherapy and Prevention of Pancreatic Cancer

Alexander H. Morrison | Katelyn T. Byrne | Robert H. Vonderheide HighlightsPancreatic cancer remains a lethal tumor that is difficult to treat and, unfortunately, immune therapies that have garnered FDA approval in other tumors have shown little efficacy to date in this tumor. These therapies include checkpoint antibodies and engineered T cell infusions. A formidable...

Post

Study validates guidelines on treating patients with an underactive thyroid

by Emma Mckinney, University of Birmingham A study led by the University of Birmingham provides strong support for current recommendations on treating patients with an underactive thyroid and validates latest UK and US guidelines, say researchers. The retrospective cohort study, published in the BMJ, analysed anonymous GP records of over 162,000 patients who have been...

Post

Major gaps exist in patient understanding of genomic test results, Lung-MAP study shows

by SWOG Cancer Research Network A majority of cancer patients don’t understand key aspects of the genomic test results they receive as participants in biomarker-driven clinical trials, according to a first-of-its-kind pilot study conducted under the Lung Cancer Master Protocol (Lung-MAP). In a September 9 presentation at the World Conference on Lung Cancer in Barcelona,...